Robert Díaz Beveridge

2.2k total citations
43 papers, 317 citations indexed

About

Robert Díaz Beveridge is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robert Díaz Beveridge has authored 43 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert Díaz Beveridge's work include Sarcoma Diagnosis and Treatment (20 papers), Vascular Tumors and Angiosarcomas (6 papers) and Cardiac tumors and thrombi (6 papers). Robert Díaz Beveridge is often cited by papers focused on Sarcoma Diagnosis and Treatment (20 papers), Vascular Tumors and Angiosarcomas (6 papers) and Cardiac tumors and thrombi (6 papers). Robert Díaz Beveridge collaborates with scholars based in Spain, Italy and France. Robert Díaz Beveridge's co-authors include Regina Gironés, Jorge Aparicio, G. Bruixola, Dilara Akhoundova, Javier Martín‐Broto, Nadia Hindi, Ángel Segura, Javier Martínez‐Trufero, Antonio Gutiérrez and Antonio López–Pousa and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Robert Díaz Beveridge

38 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Díaz Beveridge Spain 11 172 139 63 48 48 43 317
Giuseppina Arcangeli Italy 7 227 1.3× 101 0.7× 69 1.1× 58 1.2× 27 0.6× 11 336
Nuriye Özdemir Türkiye 12 214 1.2× 116 0.8× 85 1.3× 76 1.6× 68 1.4× 43 450
Stéphane Holbrechts Belgium 9 217 1.3× 112 0.8× 142 2.3× 34 0.7× 25 0.5× 29 403
Amélie Deleporte Belgium 13 277 1.6× 117 0.8× 150 2.4× 38 0.8× 48 1.0× 32 486
Osamu Nakahara Japan 13 232 1.3× 133 1.0× 183 2.9× 61 1.3× 47 1.0× 42 392
Ping‐Tsung Chen Taiwan 14 201 1.2× 126 0.9× 120 1.9× 39 0.8× 59 1.2× 35 436
Yves Rinaldi France 11 343 2.0× 132 0.9× 63 1.0× 60 1.3× 98 2.0× 47 410
Ramón Barceló Spain 9 158 0.9× 159 1.1× 48 0.8× 29 0.6× 21 0.4× 28 293
Nelleke P.M. Brouwer Netherlands 10 360 2.1× 98 0.7× 164 2.6× 91 1.9× 38 0.8× 18 513
Abdullah Sakin Türkiye 10 178 1.0× 97 0.7× 77 1.2× 29 0.6× 65 1.4× 66 294

Countries citing papers authored by Robert Díaz Beveridge

Since Specialization
Citations

This map shows the geographic impact of Robert Díaz Beveridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Díaz Beveridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Díaz Beveridge more than expected).

Fields of papers citing papers by Robert Díaz Beveridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Díaz Beveridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Díaz Beveridge. The network helps show where Robert Díaz Beveridge may publish in the future.

Co-authorship network of co-authors of Robert Díaz Beveridge

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Díaz Beveridge. A scholar is included among the top collaborators of Robert Díaz Beveridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Díaz Beveridge. Robert Díaz Beveridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beveridge, Robert Díaz, et al.. (2025). Dermatological Toxicities of Tebentafusp, a New Bispecific Drug: Case Series and Literature Review. Australasian Journal of Dermatology. 67(1). e47–e51.
2.
3.
Martín‐Broto, Javier, Robert Díaz Beveridge, David S. Moura, et al.. (2024). Phase Ib Study for the Combination of Doxorubicin, Dacarbazine, and Nivolumab as the Upfront Treatment in Patients With Advanced Leiomyosarcoma: A Study by the Spanish Sarcoma Group (GEIS). Journal of Clinical Oncology. 43(3). 297–307. 11 indexed citations
4.
Salazar, Juliana, María J. Arranz, Javier Martín‐Broto, et al.. (2024). Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol. Pharmaceutics. 16(12). 1585–1585. 1 indexed citations
5.
Martín‐Broto, Javier, Jerónimo Martínez-García, David S. Moura, et al.. (2023). Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/CDKN2A. Signal Transduction and Targeted Therapy. 8(1). 405–405. 15 indexed citations
6.
González, José Antonio, Ana Sebio, Robert Díaz Beveridge, et al.. (2023). 1932P First in human trial of CEB-01 for retroperitoneal soft tissue sarcoma. Annals of Oncology. 34. S1038–S1038. 1 indexed citations
7.
Martín‐Broto, Javier, Andrés Redondo, David S. Moura, et al.. (2022). A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors. Nature Communications. 13(1). 6278–6278. 2 indexed citations
8.
9.
Beveridge, Robert Díaz, Ana Fernández Montés, Julia Alcaide, et al.. (2019). Update of metastatic colorectal cancer metastases resection after FOLFIRI-aflibercept in oxaliplatin-refractory patients. Annals of Oncology. 30. iv51–iv52. 1 indexed citations
10.
Beveridge, Robert Díaz, Dilara Akhoundova, G. Bruixola, & Jorge Aparicio. (2017). Controversies in the multimodality management of locally advanced rectal cancer. Medical Oncology. 34(6). 102–102. 13 indexed citations
11.
12.
Beveridge, Robert Díaz, G. Bruixola, David Lorente, et al.. (2017). An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib. Clinical & Translational Oncology. 20(3). 322–329. 14 indexed citations
13.
Castells, Lluı́s, Sonia Pascual, Iratxe Díez Miranda, et al.. (2017). The ART-SCORE is not an effective tool for optimizing patient selection for DEB-TACE retreatment. A multicentre Spanish study. Gastroenterología y Hepatología. 40(8). 515–524. 8 indexed citations
14.
Poveda, Andrés, Virginia Martínez, César Serrano, et al.. (2016). SEOM Clinical Guideline for gastrointestinal sarcomas (GIST) (2016). Clinical & Translational Oncology. 18(12). 1221–1228. 16 indexed citations
15.
Martín-Richard, Marta, Robert Díaz Beveridge, Virginia Arrazubi, et al.. (2016). SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016). Clinical & Translational Oncology. 18(12). 1179–1186. 20 indexed citations
16.
Sastre, Javier, Robert Díaz Beveridge, Jesús García‐Foncillas, et al.. (2015). Clinical guideline SEOM: hepatocellular carcinoma. Clinical & Translational Oncology. 17(12). 988–995. 23 indexed citations
17.
18.
Beveridge, Robert Díaz, Jorge Aparicio, Rafael Estevan, et al.. (2012). Long-term results with oral fluoropyrimidines and oxaliplatin-based preoperative chemoradiotherapy in patients with resectable rectal cancer. A single-institution experience. Clinical & Translational Oncology. 14(6). 471–480. 2 indexed citations
19.
Ponce, José, et al.. (2007). Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables. Clinical & Translational Oncology. 9(7). 452–458. 19 indexed citations
20.
Beveridge, Robert Díaz, et al.. (2005). Carboplatin and tegafur-uracil concomitant with standard radiotherapy in the management of locally advanced head and neck cancer. Clinical & Translational Oncology. 7(1). 23–28. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuseppina Arcangeli Breakdown of academic impact, for papers by Nuriye Özdemir Breakdown of academic impact, for papers by Stéphane Holbrechts Breakdown of academic impact, for papers by Amélie Deleporte Breakdown of academic impact, for papers by Osamu Nakahara Breakdown of academic impact, for papers by Ping‐Tsung Chen Breakdown of academic impact, for papers by Yves Rinaldi Breakdown of academic impact, for papers by Ramón Barceló Breakdown of academic impact, for papers by Nelleke P.M. Brouwer Breakdown of academic impact, for papers by Abdullah Sakin
Rankless by CCL
2026